Correlation Between Valneva SE and Lipella Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Lipella Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Lipella Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Lipella Pharmaceuticals Common, you can compare the effects of market volatilities on Valneva SE and Lipella Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Lipella Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Lipella Pharmaceuticals.
Diversification Opportunities for Valneva SE and Lipella Pharmaceuticals
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Valneva and Lipella is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Lipella Pharmaceuticals Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipella Pharmaceuticals and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Lipella Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipella Pharmaceuticals has no effect on the direction of Valneva SE i.e., Valneva SE and Lipella Pharmaceuticals go up and down completely randomly.
Pair Corralation between Valneva SE and Lipella Pharmaceuticals
Given the investment horizon of 90 days Valneva SE ADR is expected to under-perform the Lipella Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Valneva SE ADR is 2.04 times less risky than Lipella Pharmaceuticals. The stock trades about -0.27 of its potential returns per unit of risk. The Lipella Pharmaceuticals Common is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 231.00 in Lipella Pharmaceuticals Common on September 19, 2024 and sell it today you would earn a total of 45.00 from holding Lipella Pharmaceuticals Common or generate 19.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Valneva SE ADR vs. Lipella Pharmaceuticals Common
Performance |
| Timeline |
| Valneva SE ADR |
| Lipella Pharmaceuticals |
Valneva SE and Lipella Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Valneva SE and Lipella Pharmaceuticals
The main advantage of trading using opposite Valneva SE and Lipella Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Lipella Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will offset losses from the drop in Lipella Pharmaceuticals' long position.| Valneva SE vs. NuCana PLC | Valneva SE vs. Sage Therapeutic | Valneva SE vs. Sellas Life Sciences | Valneva SE vs. Third Harmonic Bio |
| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |